OR WAIT 15 SECS
June 06, 2016
Shire plans to retain and expand Baxalta’s drug research outpost in Kendall Square, following its $32 billion purchase of Baxalta Inc., the Boston Globe reports.
The takeover sees Shire employ more than 3,000 workers in Massachusetts, making it the state’s second largest biopharma employer, after Sanofi Genzyme, the Globe adds.
Shire CEO Flemming Ornskov said Shire plans to expand Baxalta’s 400-person research center at Kendall Square by 100 to 200 jobs and keep an office at the research center "as a window on the entrepreneurial activity in the area".
Read the Boston Globe report here.